Board Meeting25 Sept 2026, 06:10 pm
Dr. Lal PathLabs Board Meeting on Nov 4 to Approve Q2 FY27 Results
AI Summary
Dr. Lal PathLabs Ltd has announced that its Board of Directors will convene on November 4, 2026, to consider and approve the un-audited standalone and consolidated financial results for the second quarter and half-year ending September 30, 2026. Concurrently, the company will implement a trading window closure for its securities from October 1, 2026, to November 6, 2026, in compliance with SEBI regulations on insider trading.
Key Highlights
- Board meeting scheduled for November 4, 2026.
- To approve un-audited financial results for Q2 and H1 FY27.
- Trading window to close from October 1 to November 6, 2026.
- Compliance with SEBI (Prohibition of Insider Trading) Regulations.
Price Impact
More from LALPATHLAB